Association between MTHFR c.677C>T variant and erectile dysfunction among males attending fertility clinic.

Shun Bai; Ming-zhen LI; Yang-yang Wan; Xue-chun HU; Yi-xun Liu; Xian-hong Tong; Tong-hang Guo; Lu Zong; Ran Liu; Yuan-qi Zhao; Ping Xiang; Bo XU; Xiao-hua Jiang

Return

Association between MTHFR c.677C>T variant and erectile dysfunction among males attending fertility clinic.

Author: Shun BAI ¹ ; Ming-Zhen LI ² ; Yang-Yang WAN ¹ ; Xue-Chun HU ³ ; Yi-Xun LIU ³ ; Xian-Hong TONG ¹ ; Tong-Hang GUO ¹ ; Lu ZONG ¹ ; Ran LIU ¹ ; Yuan-Qi ZHAO ¹ ; Ping XIANG ³ ; Bo XU ¹ ; Xiao-Hua JIANG ¹
Author Information

1. Department of Gynecology and Obstetrics, Reproductive and Genetic Hospital, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
2. NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou 510600, China.
3. Department of Urology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
Publication Type:Journal Article
From: Asian Journal of Andrology 2023;26(1):41-45
CountryChina
Language:English
Abstract: Genetic risk factors have been shown to contribute to the development of sexual dysfunction. However, the role of methylenetetrahydrofolate reductase (MTHFR) gene variants in the risk of erectile dysfunction (ED) remains unclear. In this study, we recruited 1254 participants who underwent ED assessed by the International Index of Erectile Function-5. The MTHFR c.677C>T variant was also measured by fluorescence polymerase chain reaction (PCR). No significant difference in the genotypic frequency of the MTHFR C677T polymorphism (CC, CT, and TT) was observed between men from the ED and non-ED groups. In addition, on binary logistic regression analysis, both crude and adjusted models showed that the risk of ED was not significantly associated with the C677T polymorphism. Interestingly, a significantly higher frequency of the 677TT polymorphism was found in severe and moderate ED (P = 0.02). The positive correlation between the MTHFR 677TT polymorphism and severe ED was confirmed by logistic regression analysis, even after adjusting for potential confounders (odds ratio [OR] = 2.46, 95% confidence interval [CI]: 1.15-5.50, P = 0.02). These findings suggest a positive correlation between the MTHFR 677TT polymorphism and the risk of severe ED. Identification of MTHFR gene polymorphisms may provide complementary information for ED patients during routine clinical diagnosis.